The Federal Trade Commission (FTC) filed a lawsuit against Hims & Hers Health, Inc. on July 29, 2026, accusing the company of illegally sharing customers' medical information with third-party advertisers like Snap and Meta Platforms. This lawsuit alleges deceptive and unlawful privacy practices, leading to a nearly 15% drop in Hims' stock price, harming investors. The Law Offices of Frank R. Cruz is investigating potential securities law violations and urging affected investors to contact them for possible claims to recover losses.
Hims & Hers Health is under federal investigation and lawsuit for alleged deceptive billing, difficult subscription cancellations, and unauthorized sharing of health data with advertisers. Barclays lowered its price target from $39 to $35, reflecting...
Hims & Hers Health has experienced a significant surge in international revenue, growing over 17-fold year-over-year to $131 million, driven by its acquisition of Eucalyptus and expansion into new markets. The company aims to exceed $600 million in i...
Berger Montague PC has initiated an investigation into Hims & Hers Health, Inc.'s Board of Directors over potential breaches of fiduciary duties. The probe focuses on allegations that the company improperly shared private user health data with advert...
Hims & Hers Health, Inc. is under investigation after the FTC sued the company for allegedly sharing customers' medical information with third-party advertisers like Snap and Meta Platforms. The lawsuit accuses Hims & Hers of deceptive and unlawful p...
